Finance

Beta
Lists
INAF:IDX
Indofarma Tbk PT
IDR 126.00
0.00%
(0.00) 1D
Jul 1, 2:55:02 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for INAF...
Mkt. cap
396.71B
Volume
0.00
52-wk high
IDR 126
52-wk low
IDR 126
EPS
-IDR 95
Shares outstanding
3.10B
No. of employees
21
Mkt. cap
396.71B
Volume
0.00
52-wk high
IDR 126
52-wk low
IDR 126
EPS
-IDR 95
Shares outstanding
3.10B
No. of employees
21
News stories
From sources across the web
About Indofarma Tbk PT
CEO-
Employees21
Founded1918
Headquarters-
SectorPharmaceutical industry
Websiteindofarma.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
36.76B
30.27B
66.71B
17.82B
Cost of goods sold
43.34B
35.60B
69.32B
22.51B
Cost of revenue
43.34B
35.60B
69.32B
22.51B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.62B
13.25B
69.13B
4.33B
Operating expense
16.08B
13.25B
76.01B
-83.07B
Total operating expenses
59.42B
48.85B
145.32B
-60.56B
Operating income
-22.65B
-18.58B
-78.62B
78.37B
Other non operating income
-
-
1.00
-1.00
EBT including unusual items
-25.44B
-18.85B
-74.21B
47.04B
EBT excluding unusual items
-25.44B
-18.85B
-74.21B
47.04B
Income tax expense
-328.81M
-411.38M
9.33B
-2.06B
Effective tax rate
1.29%
2.18%
-12.57%
-4.37%
Other operating expenses
461.55M
3.72M
6.87B
-87.40B
Net income
-25.11B
-18.44B
-83.54B
49.10B
Net profit margin
-68.30%
-60.93%
-125.23%
275.62%
Earnings per share
-
-
-
-
Interest and investment income
22.87M
18.24M
29.68M
-
Interest expense
-
-1.53B
-709.87M
-28.27B
Net interest expenses
22.87M
-1.51B
-680.19M
-28.27B
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.44B
-15.38B
-75.41B
81.58B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer